Delhi University approves up to Rs 17 crore for 9-month-old daughter of SOL teacher battling rare genetic disorder

Delhi University has taken an extraordinary and compassionate step by approving medical financial assistance of up to 17 crore rupees to support the nine-month-old daughter of a teacher employed at the School of Open Learning. The infant child has been diagnosed with a severe and rare genetic disorder that requires extremely expensive specialized medication and advanced therapy. University administrators formally approved the funding decision to help the family manage the enormous financial burden associated with this specialized life-saving treatment.

Rare genetic conditions diagnosed in infants often require specialized imported drugs or gene therapy treatments that carry multi-crore price tags, placing them far beyond the financial reach of standard medical insurance coverage and private savings. The university executive body thoroughly reviewed the emergency medical petition submitted by the family before authorizing the dedicated fund allocation. Medical experts emphasize that early administration of these specialized genetic therapies is essential to give young children a fighting chance against degenerative genetic diseases.

For readers in India, this decision highlights both the crippling cost of treatment for rare genetic diseases and the importance of institutional medical safety nets in public organizations. Most Indian families face immense financial hardship when confronting rare medical conditions because domestic healthcare coverage rarely extends to multi-crore specialized gene therapies. This intervention by a major public university sets a notable precedent for employee welfare while underscoring the broader national need for comprehensive policies on affordable rare disease treatments.